Trials / Recruiting
RecruitingNCT05876130
Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer
Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer: A Prospective Phase II Trial (POHIM_EM Trial)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 92 (estimated)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- Female
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the non-inferiority of disease-free survival in women who received hypofractionated intensity-modulated whole pelvic radiation therapy (2.5 Gy x 16 fractions) after curative surgery for stage III endometrial cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | POHIM_EM | hypofractionated intensity-modulated radiation therapy (2.5 Gy/fraction, 16 fractions) |
Timeline
- Start date
- 2022-11-01
- Primary completion
- 2031-12-31
- Completion
- 2031-12-31
- First posted
- 2023-05-25
- Last updated
- 2024-06-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05876130. Inclusion in this directory is not an endorsement.